IDO1 and acute myeloid leukemia: Additionally, the bone marrow microenvironment could hinder the cytotoxicity and proliferation of NK cells in AML through the release of immune‐suppressing cytokines, such as IL‐10, TGF‐β, IDO, and prostaglandin‐E2 (PGE2).